Clinical Trials

Investigating antiviral treatment in asthma

People with asthma are more likely to develop lower respiratory tract symptoms after an upper respiratory tract infection (URTI) even though the frequency and severity of colds in people with asthma is not higher than normal .

Clinical trials investigating the safety and efficacy of SNG001 as a broad-spectrum antiviral in specific patient populations including those with asthma.


Phase 1 safety and biomarker clinical trial of inhaled IFN-β in moderate asthmatic subjects

Download the results of this trial here.


Phase 2 clinical trial in a range of asthmatic patients, with moderate to severe asthma

The results were published in the American Journal of Respiratory and Critical Care Medicine in 2014.